Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curly Morris

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Leukemia & Lymphoma|September 22, 2016
Treatment options for relapse after autograft in multiple myeloma - report from an EBMT educational meetingLaurent Garderet, Gordon Cook, Holger W Auner, et al.
British Journal of Haematology|April 21, 2015
Bendamustine, thalidomide and dexamethasone combination therapy for relapsed/refractory myeloma patients: results of the MUKone randomized dose selection trialSteve Schey, Sarah R Brown, Avie-Lee Tillotson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2011
Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-upBo Björkstrand, Simona Iacobelli, Ute Hegenbart, et al.
British Journal of Haematology|July 11, 2006
The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation studyJennifer M Bird, Rhian Fuge, Bhawna Sirohi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 25, 2015
Efficacy and outcome of allogeneic transplantation in IgD and nonsecretory myeloma. A report on behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow TransplantationCurly Morris, Simona Iacobelli, Gösta Gahrton, et al.
Bone Marrow Transplantation|September 20, 2019
Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixaforCurly Morris, Christian Chabannon, Tamas Masszi, et al.
Transfusion|June 27, 2014
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxideCurly Morris, Liesbeth de Wreede, Marijke Scholten, et al.
Blood|March 14, 2013
Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 studyGösta Gahrton, Simona Iacobelli, Bo Björkstrand, et al.
Haematologica|September 17, 2016
High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow TransplantationGordon Cook, Simona Iacobelli, Anja van Biezen, et al.
Bone Marrow Transplantation|November 12, 2024
Satisfactory outcomes following a second autologous hematopoietic cell transplantation for multiple myeloma in poor stem cell mobilizers: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTMatjaz Sever, Joanna Drozd-Sokolowska, Luuk Gras, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|September 22, 2016
Treatment options for relapse after autograft in multiple myeloma - report from an EBMT educational meetingLaurent Garderet, Gordon Cook, Holger W Auner, et al.
British Journal of Haematology|April 21, 2015
Bendamustine, thalidomide and dexamethasone combination therapy for relapsed/refractory myeloma patients: results of the MUKone randomized dose selection trialSteve Schey, Sarah R Brown, Avie-Lee Tillotson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2011
Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-upBo Björkstrand, Simona Iacobelli, Ute Hegenbart, et al.
British Journal of Haematology|July 11, 2006
The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation studyJennifer M Bird, Rhian Fuge, Bhawna Sirohi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 25, 2015
Efficacy and outcome of allogeneic transplantation in IgD and nonsecretory myeloma. A report on behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow TransplantationCurly Morris, Simona Iacobelli, Gösta Gahrton, et al.
Bone Marrow Transplantation|September 20, 2019
Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixaforCurly Morris, Christian Chabannon, Tamas Masszi, et al.
Transfusion|June 27, 2014
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxideCurly Morris, Liesbeth de Wreede, Marijke Scholten, et al.
Blood|March 14, 2013
Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 studyGösta Gahrton, Simona Iacobelli, Bo Björkstrand, et al.
Haematologica|September 17, 2016
High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow TransplantationGordon Cook, Simona Iacobelli, Anja van Biezen, et al.
Bone Marrow Transplantation|November 12, 2024
Satisfactory outcomes following a second autologous hematopoietic cell transplantation for multiple myeloma in poor stem cell mobilizers: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTMatjaz Sever, Joanna Drozd-Sokolowska, Luuk Gras, et al.
Pageof 4